Ardsley Advisory Partners LP Aerie Pharmaceuticals Inc Transaction History

Ardsley Advisory Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$10.46 - $14.46 $2.72 Million - $3.76 Million	-260,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $360,000 - $483,899	30,000 Added 13.04%	260,000 $3.84 Million
Q1 2020 May 15, 2020	BUY	$11.84 - $25.52 $888,000 - $1.91 Million	75,000 Added 48.39%	230,000 $3.11 Million
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $2.75 Million - $3.89 Million	155,000 New	155,000 $3.75 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.